Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Acitretin | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Acitretin. |
| Aprepitant | The serum concentration of Norgestrienone can be decreased when it is combined with Aprepitant. |
| Atazanavir | The serum concentration of Norgestrienone can be increased when it is combined with Atazanavir. |
| Boceprevir | The serum concentration of Norgestrienone can be increased when it is combined with Boceprevir. |
| Prucalopride | The serum concentration of Norgestrienone can be decreased when it is combined with Prucalopride. |
| Sugammadex | The serum concentration of Norgestrienone can be decreased when it is combined with Sugammadex. |
| Thalidomide | Norgestrienone may increase the thrombogenic activities of Thalidomide. |
| Ulipristal | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Ulipristal. |
| Ursodeoxycholic acid | The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Norgestrienone. |
| Glycochenodeoxycholic Acid | The therapeutic efficacy of Glycochenodeoxycholic Acid can be decreased when used in combination with Norgestrienone. |
| Cholic Acid | The therapeutic efficacy of Cholic Acid can be decreased when used in combination with Norgestrienone. |
| Glycocholic acid | The therapeutic efficacy of Glycocholic acid can be decreased when used in combination with Norgestrienone. |
| Deoxycholic acid | The therapeutic efficacy of Deoxycholic acid can be decreased when used in combination with Norgestrienone. |
| Taurocholic acid | The therapeutic efficacy of Taurocholic acid can be decreased when used in combination with Norgestrienone. |
| Obeticholic acid | The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Norgestrienone. |
| Chenodeoxycholic acid | The therapeutic efficacy of Chenodeoxycholic acid can be decreased when used in combination with Norgestrienone. |
| Taurochenodeoxycholic acid | The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Norgestrienone. |
| Tauroursodeoxycholic acid | The therapeutic efficacy of Tauroursodeoxycholic acid can be decreased when used in combination with Norgestrienone. |
| Bamet-UD2 | The therapeutic efficacy of Bamet-UD2 can be decreased when used in combination with Norgestrienone. |
| cis-Diamminechlorocholylglycinateplatinum(II) | The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Norgestrienone. |
| Dehydrocholic acid | The therapeutic efficacy of Dehydrocholic acid can be decreased when used in combination with Norgestrienone. |
| Hyodeoxycholic Acid | The therapeutic efficacy of Hyodeoxycholic Acid can be decreased when used in combination with Norgestrienone. |
| Aramchol | The therapeutic efficacy of Aramchol can be decreased when used in combination with Norgestrienone. |
| Ox bile extract | The therapeutic efficacy of Ox bile extract can be decreased when used in combination with Norgestrienone. |
| Tranexamic acid | Norgestrienone may increase the thrombogenic activities of Tranexamic acid. |
| Clobazam | The serum concentration of Norgestrienone can be decreased when it is combined with Clobazam. |
| Colestipol | Colestipol can cause a decrease in the absorption of Norgestrienone resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sevelamer | Sevelamer can cause a decrease in the absorption of Norgestrienone resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Colesevelam | Colesevelam can cause a decrease in the absorption of Norgestrienone resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Cholestyramine | Cholestyramine can cause a decrease in the absorption of Norgestrienone resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Griseofulvin | The metabolism of Norgestrienone can be increased when combined with Griseofulvin. |
| Fluticasone propionate | The serum concentration of Fluticasone propionate can be increased when it is combined with Norgestrienone. |
| Trilostane | The serum concentration of Trilostane can be increased when it is combined with Norgestrienone. |
| Aldosterone | The serum concentration of Aldosterone can be increased when it is combined with Norgestrienone. |
| Tixocortol | The serum concentration of Tixocortol can be increased when it is combined with Norgestrienone. |
| Fluprednisolone | The serum concentration of Fluprednisolone can be increased when it is combined with Norgestrienone. |
| Melengestrol | The serum concentration of Melengestrol can be increased when it is combined with Norgestrienone. |
| Fluocortin | The serum concentration of Fluocortin can be increased when it is combined with Norgestrienone. |
| Fluperolone | The serum concentration of Fluperolone can be increased when it is combined with Norgestrienone. |
| Fluclorolone | The serum concentration of Fluclorolone can be increased when it is combined with Norgestrienone. |
| Hydrocortisone cypionate | The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Norgestrienone. |
| Dexamethasone | The serum concentration of Dexamethasone can be increased when it is combined with Norgestrienone. |
| Flunisolide | The serum concentration of Flunisolide can be increased when it is combined with Norgestrienone. |
| Beclomethasone dipropionate | The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Norgestrienone. |
| Betamethasone | The serum concentration of Betamethasone can be increased when it is combined with Norgestrienone. |
| Fluocinolone acetonide | The serum concentration of Fluocinolone acetonide can be increased when it is combined with Norgestrienone. |
| Triamcinolone | The serum concentration of Triamcinolone can be increased when it is combined with Norgestrienone. |
| Prednisone | The serum concentration of Prednisone can be increased when it is combined with Norgestrienone. |
| Hydrocortisone | The serum concentration of Hydrocortisone can be increased when it is combined with Norgestrienone. |
| Prednisolone | The serum concentration of Prednisolone can be increased when it is combined with Norgestrienone. |
| Methylprednisolone | The serum concentration of Methylprednisolone can be increased when it is combined with Norgestrienone. |
| Budesonide | The serum concentration of Budesonide can be increased when it is combined with Norgestrienone. |
| Corticotropin | The serum concentration of Corticotropin can be increased when it is combined with Norgestrienone. |
| Cortisone acetate | The serum concentration of Cortisone acetate can be increased when it is combined with Norgestrienone. |
| Paramethasone | The serum concentration of Paramethasone can be increased when it is combined with Norgestrienone. |
| Fluticasone furoate | The serum concentration of Fluticasone furoate can be increased when it is combined with Norgestrienone. |
| Fluprednidene | The serum concentration of Fluprednidene can be increased when it is combined with Norgestrienone. |
| Meprednisone | The serum concentration of Meprednisone can be increased when it is combined with Norgestrienone. |
| Dexamethasone isonicotinate | The serum concentration of Dexamethasone isonicotinate can be increased when it is combined with Norgestrienone. |
| Deflazacort | The serum concentration of Deflazacort can be increased when it is combined with Norgestrienone. |
| Cortivazol | The serum concentration of Cortivazol can be increased when it is combined with Norgestrienone. |
| Prednylidene | The serum concentration of Prednylidene can be increased when it is combined with Norgestrienone. |
| Cloprednol | The serum concentration of Cloprednol can be increased when it is combined with Norgestrienone. |
| Fluticasone | The serum concentration of Fluticasone can be increased when it is combined with Norgestrienone. |
| Mometasone furoate | The serum concentration of Mometasone furoate can be increased when it is combined with Norgestrienone. |
| Hydrocortisone acetate | The serum concentration of Hydrocortisone acetate can be increased when it is combined with Norgestrienone. |
| Hydrocortisone succinate | The serum concentration of Hydrocortisone succinate can be increased when it is combined with Norgestrienone. |
| Prednisolone phosphate | The serum concentration of Prednisolone phosphate can be increased when it is combined with Norgestrienone. |
| Prednisolone hemisuccinate | The serum concentration of Prednisolone hemisuccinate can be increased when it is combined with Norgestrienone. |
| Methylprednisolone hemisuccinate | The serum concentration of Methylprednisolone hemisuccinate can be increased when it is combined with Norgestrienone. |
| Prednisone acetate | The serum concentration of Prednisone acetate can be increased when it is combined with Norgestrienone. |
| Clocortolone acetate | The serum concentration of Clocortolone acetate can be increased when it is combined with Norgestrienone. |
| Melengestrol acetate | The serum concentration of Melengestrol acetate can be increased when it is combined with Norgestrienone. |
| Betamethasone phosphate | The serum concentration of Betamethasone phosphate can be increased when it is combined with Norgestrienone. |
| Cortisone | The serum concentration of Cortisone can be increased when it is combined with Norgestrienone. |
| Fludrocortisone | The serum concentration of Fludrocortisone can be increased when it is combined with Norgestrienone. |
| Ciclesonide | The serum concentration of Ciclesonide can be increased when it is combined with Norgestrienone. |
| Clobetasol propionate | The serum concentration of Clobetasol propionate can be increased when it is combined with Norgestrienone. |
| Fluocinonide | The serum concentration of Fluocinonide can be increased when it is combined with Norgestrienone. |
| Hydrocortisone butyrate | The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Norgestrienone. |
| Desoximetasone | The serum concentration of Desoximetasone can be increased when it is combined with Norgestrienone. |
| Mometasone | The serum concentration of Mometasone can be increased when it is combined with Norgestrienone. |
| Fluocortolone | The serum concentration of Fluocortolone can be increased when it is combined with Norgestrienone. |
| Prednisolone acetate | The serum concentration of Prednisolone acetate can be increased when it is combined with Norgestrienone. |
| Fluorometholone | The serum concentration of Fluorometholone can be increased when it is combined with Norgestrienone. |
| Difluocortolone | The serum concentration of Difluocortolone can be increased when it is combined with Norgestrienone. |
| Flumethasone | The serum concentration of Flumethasone can be increased when it is combined with Norgestrienone. |
| Methylprednisolone aceponate | The serum concentration of Methylprednisolone aceponate can be increased when it is combined with Norgestrienone. |
| Vitamin A | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Vitamin A. |
| Bexarotene | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Bexarotene. |
| Alitretinoin | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Alitretinoin. |
| Tretinoin | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Tretinoin. |
| Tazarotene | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Tazarotene. |
| Etretinate | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Etretinate. |
| Isotretinoin | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Isotretinoin. |
| 4-Oxoretinol | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with 4-Oxoretinol. |
| Fenretinide | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Fenretinide. |
| Ro 12-7310 | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Ro 12-7310. |
| Zuretinol acetate | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Zuretinol acetate. |
| Motretinide | The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Motretinide. |